Press Release
2022/027 from 11/02/2022 - Following surgery, patients with breast cancer are faced with the question of whether additional chemotherapy is necessary and really effective. It is important that these women do not receive too much treatment –...
WHO’s prequalification adds to several mechanisms already in place to improve access to Actemra/RoActemra for people with COVID-19 in low- and middle-income countries Since the beginning of the pandemic, more than one million...
CU Cancer Center member Sachin Wani, MD, is leading a study to test the effectiveness of a novel diagnostic tool to improve detection of early esophageal cancer. On a mission to increase early detection of esophageal cancer, University of...
Combination enhances service offering for hospitals, physicians and patients of both companies NASHVILLE, Tenn.— January 24, 2022 – PathGroup, one of the largest providers of anatomic pathology, digital pathology, clinical, and...
Nijmegen, The Netherlands – LUMO Labs’ pre-seed investment vehicle LUMO Fund II TTT AI announces an investment in Aiosyn B.V. Aiosyn’s clinical diagnostics platform uses AI-powered pathology algorithms to support pathologists with more...
Multi-year agreement will power 100% digitization of Uppsala’s clinical workflow and future AI integrations UPPSALA, Sweden & PHILADELPHIA, PA - February 3, 2022 - Proscia®, the leader in digital and computational...
